Loading…
Back To Schedule
Wednesday, October 3 • 2:30pm - 3:10pm
Strengthen Immuno-Oncology Portfolios Through Relevant Preclinical Models of Disease

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Gain access to patient-derived xenoblast models as translational tools 
  • Develop faithful models that represent tumor biology and the intersection of the immune microenvironment and system
  • Reach the next step in providing humanized mouse immune systems

Moderators
avatar for David Sherris

David Sherris

CEO, GENADAM THERAPEUTICS

Speakers
avatar for Ronald Herbst

Ronald Herbst

Vice President, R&D, Head of Oncology Research, MEDIMMUNE
PS

Peter Smith

CSO, H3 BIOMEDICINE


Wednesday October 3, 2018 2:30pm - 3:10pm EDT
Hilton Boston Logan Airport